Mounjaro—a once celebrated drug for diabetes now stands at the epicenter of a storm. The drug which was intended for type 2 diabetes, has found itself under the harsh scrutiny of lawsuits. It blocks the glucagon-like peptide 1 (GLP-1) receptor and a gastric inhibitory polypeptide (GIP).

On May 13, 2022, the FDA approved Mounjaro injection as a medication for type 2 diabetes mellitus. The first Mounjaro lawsuit was filed in August 2023 by the plaintiff Jaclyn Bjorklund. Another lawsuit was filed by Blake, a 38 year old man who took two doses of Mounjaro for diabetes. 

The plaintiffs allege that the drug manufacturer failed to warn the users about stomach paralysis. It is estimated that around 10,000 claims are under the investigation stage.

Are you harmed by the adverse effects of Mounjaro?  It’s the right time to consult an expert Mounjaro lawsuit lawyer with medical record review support.